Mapping Report - Ireland.
BMC Public Health (2016) 16:766
DOI 10.1186/s12889-016-3455-5
A Systematic Review and Meta-analysis
Clinical Infectious Diseases® 2016;62(12):1586–94
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Méthodologie pour l’élaboration d’un plan stratégique national
Principales composantes du PSN
Training leaders in public health
IMDP 2016 Training Catalogue
A long and healthy life for all South Africans
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
Strengthening Community responses to HIv Treatment and Prevention
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
12-13 December 2016
Global Action Plan on HIV Drug Resistance - Webinars 12-13 December 2016
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.